Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S Schnittger

Early Molecular and Cytogenetic Response Is Predictive for Long-Term Progression-Free and Overall Survival in Chronic Myeloid Leukemia (CML)

Leukemia

English

Mutation Analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 Patients With MDS or Secondary AML

English

Long-Term Outcome of Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Randomized Comparison of Stem Cell Transplantation With Drug Treatment

English

Landscape of TET2 Mutations in Acute Myeloid Leukemia

English

Landscape of Genetic Lesions in 944 Patients With Myelodysplastic Syndromes

English

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed Within the European LeukemiaNet

English

An Accumulation of Cytogenetic and Molecular Genetic Events Characterizes the Progression From MDS to Secondary AML: An Analysis of 38 Paired Samples Analyzed by Cytogenetics, Molecular Mutation Analysis and SNP Microarray Profiling

English

SOX11 Overexpression Is a Specific Marker for Mantle Cell Lymphoma and Correlates With T(11;14) Translocation, CCND1 Expression and an Adverse Prognosis

English

Establishing Optimal Quantitative-Polymerase Chain Reaction Assays for Routine Diagnosis and Tracking of Minimal Residual Disease in JAK2-V617F-associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/MPN&MPNr-EuroNet (COST Action BM0902) Study

English

BAALC Expression: A Suitable Marker for Prognostic Risk Stratification and Detection of Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S Schnittger

Early Molecular and Cytogenetic Response Is Predictive for Long-Term Progression-Free and Overall Survival in Chronic Myeloid Leukemia (CML)

Mutation Analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 Patients With MDS or Secondary AML

Long-Term Outcome of Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Randomized Comparison of Stem Cell Transplantation With Drug Treatment

Landscape of TET2 Mutations in Acute Myeloid Leukemia

Landscape of Genetic Lesions in 944 Patients With Myelodysplastic Syndromes

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed Within the European LeukemiaNet

An Accumulation of Cytogenetic and Molecular Genetic Events Characterizes the Progression From MDS to Secondary AML: An Analysis of 38 Paired Samples Analyzed by Cytogenetics, Molecular Mutation Analysis and SNP Microarray Profiling

SOX11 Overexpression Is a Specific Marker for Mantle Cell Lymphoma and Correlates With T(11;14) Translocation, CCND1 Expression and an Adverse Prognosis

Establishing Optimal Quantitative-Polymerase Chain Reaction Assays for Routine Diagnosis and Tracking of Minimal Residual Disease in JAK2-V617F-associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/MPN&MPNr-EuroNet (COST Action BM0902) Study

BAALC Expression: A Suitable Marker for Prognostic Risk Stratification and Detection of Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia